HealO Medical
Developer of a pre-commercial, multi‑modal wound treatment platform that integrates programmable negative pressure wound therapy with topical pressurized oxygen and ports for topical therapeutic instillation. The technology is intended to optimize the wound micro‑environment, support incubation of biologic therapies, reduce dressing changes and nursing burden, and enable home-based care. The company is headquartered in Sarasota/Osprey, Florida and has pursued patent protection and premarket regulatory planning toward FDA 510(k) clearance.
Industries
Nr. of Employees
small (1-50)
HealO Medical
Products
Multi‑modal wound treatment control platform
A portable control module that coordinates programmable expansile negative pressure therapy with pulsed pressurized topical oxygen and routes instillation/evacuation through disposable wound interfaces to optimize wound healing.
Transparent wound chamber dressing
A clear wound chamber designed to provide visual assessment of the wound and ports for irrigation, topical therapies and exudate management.
Advanced topical therapeutic dressing
A super dressing designed to deliver therapeutics directly to the wound bed and to work with the control module for combined NPWT and oxygen therapy.
Multi‑modal wound treatment control platform
A portable control module that coordinates programmable expansile negative pressure therapy with pulsed pressurized topical oxygen and routes instillation/evacuation through disposable wound interfaces to optimize wound healing.
Transparent wound chamber dressing
A clear wound chamber designed to provide visual assessment of the wound and ports for irrigation, topical therapies and exudate management.
Advanced topical therapeutic dressing
A super dressing designed to deliver therapeutics directly to the wound bed and to work with the control module for combined NPWT and oxygen therapy.
Services
Clinical collaboration and study participation
Engagement with clinicians for device assessment, letters of support, and potential participation in pre‑market clinical studies.
Clinical collaboration and study participation
Engagement with clinicians for device assessment, letters of support, and potential participation in pre‑market clinical studies.
Expertise Areas
- Advanced wound care device development
- Negative pressure wound therapy (NPWT) optimization
- Topical pressurized oxygen therapy
- Incubation and delivery of biologics in wound environments
Key Technologies
- Negative pressure wound therapy (NPWT) — cyclical/expansile
- Pressurized topical oxygen delivery
- Programmable therapeutic control modules
- Sealed wound chamber interfaces for visualization